Document Detail

Treatment of smell loss with systemic methylprednisolone.
MedLine Citation:
PMID:  22888485     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND AIM: Olfactory dysfunction is a common complaint in a large number of people. As the aetiologies of olfactory dysfunction vary greatly so do the treatment approaches. The aim of this retrospective study was to evaluate treatment with systemic corticosteroids, particularly focusing on its effectiveness on the different olfactory dysfunction aetiologies. Although a prospective randomized control trail is preferred for such an investigation, using the current approach, we were able to test a very large patient population.
MATERIAL AND METHODS: A total of 425 patients with olfactory dysfunction were treated with systemic corticosteroids for 14 days. Olfactory performance was measured using the `Sniffin` Sticks` battery before and after the treatment.
RESULTS: The treatment with systemic corticosteroids significantly increased the performance on the TDI score and on each of the three subtests; threshold, discrimination and identification. In 26.6% of the patients improvement of more than six points of the TDI score was observed. The treatment proved to be more effective in patients with sinunasal olfactory dysfunction, where this percentage increased to 36.7, compared to other aetiologies. In addition, the increase in olfactory function was negatively correlated with the TDI score before the treatment.
CONCLUSION: This study confirms the effectiveness of systemic corticosteroids on olfactory dysfunction in a large patient population. Specifically, the results show that treatment is: (a) more effective in patients with sinunasal than in patients with idiopathic olfactory dysfunction, (b) most effective in patients with sinunasal disease with nasal polyps, and (c), at best, effective in half of the patients. The current study may provide help in counselling patients.
V A Schriever; C Merkonidis; N Gupta; C Hummel; T Hummel
Related Documents :
3470705 - Urinary excretion of lactate, 2-oxoglutarate, citrate, and glycerol in patients with gl...
22466495 - Voice in chronic hemodialyzed individuals.
21772695 - Perioperative management of patient with alkaptonuria and associated multiple comorbidi...
22469335 - Dengue in patients with central nervous system manifestations, brazil.
20587875 - Beta-2 microglobulin levels in hemodialysis patients.
6693915 - Necrotising leukoencephalopathy complicating treatment of childhood leukaemia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Rhinology     Volume:  50     ISSN:  0300-0729     ISO Abbreviation:  Rhinology     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-13     Completed Date:  2013-02-12     Revised Date:  2013-06-15    
Medline Journal Info:
Nlm Unique ID:  0347242     Medline TA:  Rhinology     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  284-9     Citation Subset:  IM    
Department of Otorhinolaryngology, University of Dresden Medical School, Dresden, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Drug Administration Schedule
Glucocorticoids / administration & dosage*
Methylprednisolone / administration & dosage*
Middle Aged
Olfaction Disorders / drug therapy*,  etiology,  physiopathology
Olfactory Perception / physiology
Retrospective Studies
Sensory Thresholds / physiology
Treatment Outcome
Young Adult
Reg. No./Substance:
0/Glucocorticoids; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformation...
Next Document:  Investigation of the topographical differences in somatosensory sensitivity of the human nasal mucos...